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Abstract 
Platelets promote wound healing by forming a vascular plug and by secreting growth factors and 
cytokines. Glycoprotein (GP)VI and C-type lectin-like receptor (CLEC)-2 signal through a (hem)-
immunoreceptor tyrosine-based activation motif, which induce platelet activation. GPVI and CLEC-2 
support vascular integrity during inflammation in the skin through regulation of leukocyte migration 
and function, and by sealing sites of vascular damage. In this study, we have investigated the role of 
impaired vascular integrity due to GPVI and/or CLEC-2 deficiency in wound repair using a full-thickness 
excisional skin wound model in mice. Transgenic mice deficient in both GPVI and CLEC-2 exhibited 
accelerated skin wound healing, despite a marked impairment in vascular integrity. The local and 
temporal bleeding in the skin led to greater plasma protein entry, including fibrinogen and clotting 
factors, was associated with increased fibrin generation, reduction in wound neutrophils and M1 
macrophages, decreased level of tumor necrosis factor (TNF)-α, and enhanced angiogenesis at day 3 
after injury. Accelerated wound healing was not due to developmental defects in CLEC-2 and GPVI 
double-deficient mice as similar results were observed in GPVI-deficient mice treated with a 
podoplanin-blocking antibody. The rate of wound healing was not altered in mice deficient in either 
GPVI or CLEC-2. Our results show that contrary to defects in coagulation, bleeding following a loss of 
vascular integrity caused by platelet CLEC-2 and GPVI deficiency facilitates wound repair by increasing 
fibrin(ogen) deposition, reducing inflammation, and promoting angiogenesis. 
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Introduction 
Cutaneous wound repair is a complex process, which requires a well-regulated interplay between 
diverse cell types and molecules.
1
 Four interrelated phases of wound healing have been described 
namely hemostasis, inflammation, proliferation, and remodeling.
1
 Immediately upon injury, platelets 
and fibrin generate a hemostatic plug to prevent excessive blood loss. Additionally, the fibrin clot 
forms a scaffold to promote migration of local cells surrounding the wound.
2
 Deficiency in clotting 
factors, including tissue factor (TF), factor (F)VII or FIX, results in persistent intra-tissue bleeding and 
delayed wound healing.
3-5
 Shortly after, neutrophils and inflammatory macrophages (M1) are recruited 
to eliminate microbes and cellular debris, driving the inflammatory phase.
1,6
 During the proliferative 
phase, re-epithelialization and angiogenesis promote cell growth and wound recovery. In addition, 
fibroblasts infiltrate the granulation tissue to produce extracellular matrix proteins, and to differentiate 
into myofibroblasts, mediating wound contraction.
1
 In parallel, the number of M2 reparative 
macrophages increases, contributing to resolution of inflammation.
1,6
 Complete wound closure and re-
organization of collagen fibers restore skin integrity during the remodeling phase.
1
 
Platelets play several roles in wound healing during the hemostatic, inflammatory, and vascular repair 
phases.
7
 Platelets secrete chemoattractants and growth factors that mediate cell recruitment and 
tissue repair, respectively.
1,7,8
 This is illustrated by the delay in healing of corneal epithelial abrasion in 
thrombocytopenic and P-selectin-deficient mice.
9
 Moreover, platelet-rich plasma, which contains 
growth factors, promotes skin wound healing in mice
10
 and is a possible therapeutic agent to facilitate 
wound repair. 
Platelet immunoreceptor tyrosine-based activation motif (ITAM) receptors, GPVI and CLEC-2, share a 
common Src/Syk/PLCγ2-dependent signaling pathway leading to platelet activation.
11
 A primary role 
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for GPVI and a secondary role for CLEC-2 in maintaining vascular integrity in the inflamed skin has been 
demonstrated.
12,13
 In addition, CLEC-2 and GPVI are key regulators of inflammation. GPVI promotes a 
pro-inflammatory phenotype during glomerulonephritis
14
, arthritis
15
, and dermatitis
16
. The CLEC-2-
podoplanin axis is anti-inflammatory and protects against organ damage during lung and systemic 
inflammation.
17,18
  
Due to the complex interplay between platelets and inflammation during wound healing, we 
hypothesize that GPVI and/or CLEC-2 regulate vascular integrity during wound repair and alter the 
healing process. In the present study, we show that deletion of both CLEC-2 and GPVI accelerates 
wound healing in a mouse model of full-thickness excisional skin wound repair. This is associated with 
a transient and self-limited bleeding (i.e. due to impaired vascular integrity), fibrin(ogen) matrix 
deposition, a reduction in wound neutrophils and M1 macrophages, and increased angiogenesis during 
the inflammatory phase. Taken together, we show that impaired vascular integrity-induced bleeding is 
beneficial during a model of sterile wound healing. 
 
Methods 
Animals 
Male and female WT, platelet-specific CLEC-2-deficient (Clec1b
fl/fl
Pf4-Cre), GPVI
 
knockout (Gp6
-/-
), and 
CLEC-2/GPVI double-deficient (Clec1b
fl/fl
Pf4-Cre/Gp6
-/-
; DKO) mice aged 8-10 weeks were used. All 
experiments were performed in accordance with UK laws (Animal [Scientific Procedures] Act 1986) 
with approval of local ethics committee and UK Home Office under PPL P0E98D513 and P14D42F37, 
respectively. 
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Full-thickness excisional skin wound model 
A single full-thickness excisional skin wound was made on the shaved flank skin of mice using a 4 mm-
diameter biopsy punch (Kai Industries, Japan). Wounds were imaged using a Nikon COOLPIX B500 
digital camera each day and wound size measured using calipers
19
 on a daily basis for up to nine days 
post-injury. Wound area was calculated as described
19
 and presented as the percentage of initial 
wound size
10
. In a second set of experiments, anti-podoplanin antibody (clone 8.1.1, 100 µg)
13,17,20
 or 
IgG isotype control were intravenously injected 24 hours before and again 24 hours after wounding. 
Wound size was monitored for three days post-injury.  
 
Other associated methods 
For details, see supplemental materials. 
 
Results 
CLEC-2 and GPVI ligands are present within perivascular areas during skin wounding 
In unchallenged WT mouse skin, collagen was abundantly expressed throughout the dermis and 
hypodermis, including around blood vessels, and podoplanin was predominantly expressed on 
lymphatic endothelial cells and on perivascular cells (Figure S1A, B). At day 3 post-wounding, 
podoplanin expression was also observed surrounding blood vessels in WT and transgenic mice (Figure 
1A). These podoplanin-expressing cells included pericytes (neuron-glial antigen 2; NG2
+
) (Figure 1A), 
fibroblasts (vimentin
+
), infiltrating monocytes (Ly6C
+
) and macrophages (F4/80
+
) (Figure 1B). In 
addition, podoplanin was upregulated on migrating keratinocytes, and on stromal and infiltrating cells 
within the granulation tissue (Figure S1C). The level of perivascular podoplanin was increased in 
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Clec1b
fl/fl
Pf4-cre mice compared to WT mice (Figure 1A, B). In DKO mice, podoplanin expression was 
similar to that observed in WT and Gp6
-/-
 mice (Figure 1A, B).  
Three days after wound injury, platelets (CD41
+
) were observed in close proximity to the vessel wall 
(surrounded by pericytes) in WT, Clec1b
fl/fl
Pf4-cre, and Gp6
-/-
 mice (Figure 1A arrow). In DKO mice, 
platelets were more widely distributed, including at the vessel wall and in the surrounding tissue 
(Figure 1A star). The platelet count in Clec1b
fl/fl
Pf4-cre and DKO mice was approximately 25% and 40% 
lower than in WT, respectively (Figure S1D) and was not altered by wound injury. 
These results demonstrate that platelets are present in perivascular areas during the initial wound 
healing process in mouse skin where the ligands for GPVI and CLEC-2 are also observed. Deletion of 
CLEC-2 from platelets is associated with increased podoplanin-expressing cells in the perivascular space 
during wound healing while concurrent ablation with GPVI reverses this phenotype.  
 
Cutaneous wound healing is accelerated in mice deficient in platelet CLEC-2 and GPVI 
To determine the contribution of platelet ITAM receptors in wound repair, we monitored the time 
course of wound closure in WT and platelet ITAM receptor(s)-deficient mice. All mouse strains 
exhibited complete wound closure within nine days post-injury (Figure 2A). However, mice deficient in 
both GPVI and CLEC-2 demonstrated accelerated repair (Figure 2B), characterized by the presence of a 
dark scab and redness around the wound (Figure 2A), especially within the first three days after injury 
compared to WT and single ITAM-deficient mice. There was no discernable difference in wound 
appearance in all mouse strains after four days post-injury (Figure 2A) and wound size was not 
macroscopically different at day 9 post-injury (Figure 2B). However, the morphometric analysis of skin 
histology at this time revealed a significant smaller scar in DKO mice, as shown by a shorter length of 
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hyperplastic epidermis compared to WT and Clec1b
fl/fl
Pf4-cre mice (Figure 2C, D) and a narrower inter-
subcutaneous gap than WT mice (Figure 2C, E). 
At day 3 post-injury, re-epithelialization was observed in all groups (Figure 3A). However, this process 
was enhanced in DKO mice compared to WT and Clec1b
fl/fl
Pf4-cre mice but not Gp6
-/- 
mice (Figure 3B). 
There was no significant difference in wound contraction between all tested groups (Figure 3C). DKO 
mice also had a larger area of granulation tissue compared to WT mice (Figure 3A, D). Improved wound 
healing was associated with enhanced angiogenesis as assessed by the increase in CD31
+
 area in DKO 
animals at day 3 post-injury (Figure 3E, F) although the density of blood vessels (CD31
+
) and lymphatic 
vessels (podoplanin
+
) in unchallenged skin was similar among all groups (Figure S1E, F). 
These results demonstrate that deletion of both CLEC-2 and GPVI accelerates skin wound closure, 
enhances re-epithelialization and angiogenesis, and reduces scar formation.  
 
GPVI and CLEC-2 maintain vascular integrity during the inflammatory phase of wound repair 
The redness surrounding the wound in DKO mice in the inflammatory phase is indicative of increased 
vascular leakiness. Macroscopic examination of the skin at day 3 post-injury demonstrated vasodilation 
and bleeding into the wound as well as into the surrounding skin in DKO mice, with less severe vascular 
leakage seen in Gp6
-/-
 mice (Figure 4A). H&E staining confirmed the extravasation of red blood cells 
(RBCs) in the dermis at the edge of the wound at day 3 post-injury in both DKO and Gp6
-/-
 mice (Figure 
S2A). Clearance of extravascular RBCs was observed at day 9 post-injury in all groups (Figure S2B). Due 
to blood/lymphatic mixing phenotype in DKO and to a lesser degree in Clec1b
fl/fl
Pf4-cre mice, RBCs 
were also present in lymphatic vessels (podoplanin
+
) (Figure S2C).  
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These observations demonstrate marked impairment of vascular integrity during the inflammatory 
phase of wound repair in DKO mice with a milder phenotype in Gp6
-/-
 mice. Vascular leakage is 
diminished in later phases when inflammation subsides. 
 
GPVI and CLEC-2 deficiency increases fibrin(ogen) deposition during the inflammatory phase of repair  
Increased vascular permeability results in leakage of blood cells and plasma proteins into the wound
21
 
where they come in contact with TF
5,22
, which activates the extrinsic pathway of blood coagulation. An 
increase in fibrinogen deposition was particularly marked in the granulation tissue at day 3 post-injury 
(Figure 4B, C) with no significant alteration in TF expression in DKO mice (Figure S3A, B). Fibrin content 
in the wound scab was similar between WT and DKO mice at day 1 post-injury (Figure S3C, D), but was 
significantly increased in the DKO mice at day 3 post-injury, compared to WT and Clec1b
fl/fl
Pf4-cre mice 
but not to Gp6
-/- 
mice, which exhibited a more moderate vascular leakage (Figure 4D, E). At day 9 post-
injury, fibrin was mainly located on the upper part of the scar in all groups (Figure 4F) and was notably 
lower in the DKO mice compared to WT and Gp6
-/-
 mice (Figure 4G). There was no significant 
difference in wound (myo)fibroblasts (Figure S3E-G) and collagen content (Figure S3H, I) between DKO 
mice and WT at day 3 and day 9 post-injury. 
These results indicate that the loss of vascular integrity during the inflammatory phase increases 
extravasation of plasma proteins, including fibrinogen and clotting factors, into the wound of DKO 
mice. The increase in fibrinogen and fibrin deposition is associated with accelerated wound healing and 
is then cleared from the healing wound. 
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Platelet ITAM receptor deficiency reduces wound neutrophils and M1 macrophages during the 
inflammatory phase 
The influx of inflammatory cells was investigated at days 1, 3, and 9 post-injury. Neutrophil (Gr-1
+
) 
infiltration on day 1 post-injury was similar between WT and DKO mice (Figure S4A, B). At day 3 post-
injury, DKO mice showed a significant impairment in neutrophil infiltration compared to WT and 
Clec1b
fl/fl
Pf4-cre mice but not Gp6
-/-
 mice (Figure 5A, B). The decrease in neutrophil infiltration was 
confirmed using anti-Ly6G antibody clone 1A8 (data not shown). A two-fold increase in wound 
neutrophils was observed in WT but not in DKO mice at this time relative to day 1 post-injury (Figure 
5C). At day 9 post-injury, DKO mice showed higher number in wound neutrophils than WT (Figure 5D, 
E) although neutrophil level was significantly decreased in both groups relative to day 1 and day 3 post-
injury (Figure 5C). Blood neutrophil counts were similar in unchallenged mice across all groups (Figure 
5F). At day 3 post-injury, the number of blood neutrophils was significantly decreased in WT and 
Clec1b
fl/fl
Pf4-cre (Figure 5F) while remaining unaltered during the time course of wound healing in DKO 
and Gp6
-/-
 mice (Figure 5F). The decrease in neutrophil infiltration was not due to a defect of 
chemoattractants at the wound site as measured by the presence of chemokine CXCL-1 (Figure S6A, B) 
or platelet factor 4 (PF4) (Figure S6C, D).  In vitro migration towards N-formyl-methionyl-leucyl-
phenylalanine (fMLP) using bone marrow-derived neutrophils demonstrated that migration of 
neutrophils from WT mice was attenuated by fibrinogen, and strongly inhibited by crosslinked fibrin 
compared to the migration through collagen (Figure S7). Fibrinogen and fibrin showed a similar degree 
of inhibition for the migration of neutrophils from DKO mice (Figure S7). 
There was no significant difference in wound monocytes (Ly6C
+
) at day 1 post-injury between DKO 
mice and WT (Figure S4C, D). At day 3 post-injury, DKO mice showed a significantly higher number of 
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wound monocytes compared to all other strains (Figure 6A, B), which was reflected by a four-fold 
increase in wound monocytes relative to day 1 post-injury (Figure 6C). At day 9 post-injury, monocytes 
within the wound remained at low level in WT and single-knockout mice (Figure 6D, E). Wound 
monocytes in DKO mice were decreased at this time relative to day 3 post-injury (Figure 6C), but 
remained higher than other groups (Figure 6D, E). In blood, Clec1b
fl/fl
Pf4-cre exhibited an increase in 
baseline circulating monocytes compared to WT and DKO mice (Figure S4G, left). Blood monocytes 
were greatly reduced at day 3 and day 9 post-injury in all groups compared to their unchallenged 
controls (Figure 6F). However, the level of blood monocytes in DKO mice was significantly higher than 
Clec1b
fl/fl
Pf4-cre mice at day 3 post-injury (Figure S4G, middle) and then all groups at day 9 post-injury 
(Figure S4G, right). 
The influx of macrophages (F4/80
+
) in DKO mice was reduced at day 1 post-injury compared to WT 
(Figure S4E, F). At day 3 post-injury, wound macrophages in Clec1b
fl/fl
Pf4-cre mice were elevated, 
compared to all other strains (Figure 7A, B). A six-fold increase in wound macrophages was observed in 
WT mice at day 3 relative to day 1 post-injury (Figure 7C). DKO mice showed a significant reduction in 
macrophages compared to WT but not Gp6
-/- 
mice at this time (Figure 7B, C). Inducible nitric oxide 
synthase (iNOS)-expressing macrophages (M1 phenotype) (Figure 7D, E) and TNF-α level (Figure 7G, H) 
within the wound of DKO mice were decreased whereas Fizz-1-positive macrophages (a M2 marker) 
were similar to WT (Figure S5D, E) at day 3 post-injury. At day 9 post-injury, wound macrophages in 
DKO mice were similar to WT and Clec1b
fl/fl
Pf4-cre mice (Figure S5D, E) with no difference in M1 
(Figure 7D, F) and M2 macrophages (Figure S5A, C) between WT and DKO strains. Gp6
-/-
 mice showed a 
lower number of macrophages within the wound scar than in Clec1b
fl/fl
Pf4-cre mice at day 9 post-injury 
(Figure S5E).  
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Overall, these data illustrate that CLEC-2 deletion promotes leukocyte sequestration in the wound 
during the inflammatory phase, especially macrophages. Deletion of both ITAM receptors leads to a 
significant reduction in wound neutrophils and M1 macrophages during this phase and a decrease in 
TNF-α expression in the tissue.  
 
Inhibition of CLEC-2-podoplanin axis accelerates wound healing in GPVI-deficient mice 
Clec1b
fl/fl
Pf4-cre and DKO mice present with blood/lymphatic mixing and moderate 
thrombocytopenia.
11,17
 To investigate the influence of these defects on wound healing, we injected 
Gp6
-/-
 mice with an antibody to podoplanin (anti-podoplanin-treated Gp6
-/-
 mice) that blocks CLEC-2-
podoplanin interaction. A significant acceleration in wound healing was observed in anti-podoplanin-
treated Gp6
-/-
 mice at day 2 and day 3 post-injury (Figure 8A, B), in association with enhanced vascular 
leakage (Figure 8A, C) and increased fibrin deposition (Figure 8D, E). Moreover, decreased wound 
neutrophils (Figure 8F, G) and macrophages (Figure 8H, I), and higher wound monocytes (Figure S8A, B) 
but unaltered level of TNF-α (Figure S8C, D) were observed in anti-podoplanin-treated Gp6
-/-
 mice. The 
re-epithelialization (Figure S8E, F), granulation tissue formation (Figure S8E, H) and angiogenesis 
(Figure S8I, J) were also increased in anti-podoplanin-treated Gp6
-/-
 mice. However, wound contraction 
was not significantly changed (Figure S8E, G).  Similar to DKO mice, extravasation of platelets was 
detected together with the presence of anti-podoplanin antibody on pericytes and other perivascular 
cells in anti-podoplanin-treated Gp6
-/-
 mice at this time (Figure S9). 
These data indicate that the accelerated wound healing in DKO mice is not due to developmental 
defects or thrombocytopenia, but due to a combined loss of the interaction of platelet CLEC-2 and 
GPVI with their respective ligands. 
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Discussion 
In this study, we show that combined deletion of platelet CLEC-2 and GPVI promotes healing of a full-
thickness skin wound in mice compared to WT or single-knockout mice. The accelerated wound closure 
is accompanied by impairment of vascular integrity, rapid re-epithelialization and an increase in 
granulation tissue formation, resulting in a smaller wound scar. This is also associated with elevated 
levels of fibrinogen and fibrin in the tissue, reduced infiltration of leukocytes, and enhanced 
angiogenesis. A proposed model for the multifactorial regulation of accelerated wound healing in the 
absence of the two ITAM receptors is shown in Figure S10. 
Wound healing is a multistep process involving coagulation, vascular permeability changes, 
inflammation, cell proliferation and cell migration.
1,2,21
 In our study, we show that deletion of CLEC-2 
and GPVI in platelets leads to increased bleeding into the wound, in association with accelerated 
wound repair. These effects are not due to blood/lymphatic vessel mixing or the reduction in platelet 
count in the DKO mice as similar results were observed in anti-podoplanin-antibody treated Gp6
-/-
 
mice, which do not have these defects.  Acceleration of wound healing is also observed in mice treated 
with histamine
23
 or serum fraction of the natural latex from rubber tree
21
, which enhances vascular 
permeability, a milder form of vascular leakage. Therefore, impaired vascular integrity as seen in the 
DKO platelets or increased permeability leads to extravasation of growth factors, cytokines, and 
plasma proteins to the tissue, and promotion of wound healing. 
The role of blood coagulation in wound repair has been studied in mice expressing low TF
5
 or lacking 
FIX (hemophilia B mice)
3,5
. In these two models, the deficiency in clotting factors leads to a persistent 
hematoma formation (due to a prolonged subcutaneous bleeding) and a reduction in fibrin generation, 
13 
 
both of which contribute to a delay in wound repair. Chronic hemorrhage also contributes to the non-
healing wound characteristics in cancers, which promotes tumor growth.
24-26
 In contrast, we show that 
in the presence of an intact coagulation cascade, the transient and self-limited bleeding into the 
wound (which is rich in TF
5,22
) caused by the impairment of vascular integrity at an initial stage, is 
associated with accelerated wound repair. This is most likely due to increased entry of platelets, 
clotting factors, and plasma proteins, leading to fibrinogen accumulation and fibrin generation. Thus, 
the mechanism of bleeding determines whether it is beneficial or detrimental in wound repair.  
Fibrinogen and fibrin are not only crucial for clot formation, but also act as a natural suture/sealant, 
providing a matrix for cell migration as well as a reservoir for growth factors and cytokines.
2
 For 
example, fibrin exposes plasminogen to migrating keratinocytes, which in turn convert plasminogen 
into plasmin to mediate fibrinolysis, allowing the cells to move along the fibrin(ogen) matrix.
27-29
 
Similarly, endothelial cells proliferate and migrate over fibrin(ogen), form a capillary tube, contributing 
to angiogenesis during wound healing.
30-32
 In DKO mice, we therefore propose that fibrin(ogen) 
accumulation promotes re-epithelialization and angiogenesis and accelerate wound repair.  
In contrast, fibrinogen
33
 and a high concentration of fibrin
34
 inhibit neutrophil migration as previously 
reported and in line with our in vitro data. These data may explain our observations that in DKO mice, 
wound neutrophils at day 3 did not increase over the amount seen at day 1 post-injury. This is in 
contrast to wound neutrophil accumulation in WT, which was higher at day 3 than at day 1 post-injury. 
Increased fibrin content in the wound was also observed in DKO mice compared to WT at day 3 post 
injury. Therefore, the physical obstruction and anti-migratory properties of the fibrin clot is likely to 
inhibit neutrophil wound entry observed in DKO mice. Moreover, given that the level of blood 
neutrophils at this early phase was not significantly different between WT and DKO mice, altered 
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neutrophil turnover/apoptosis in DKO mice is unlikely to significantly contribute to the reduction in 
wound neutrophils observed in DKO compared to WT at day 3 post-injury.  
Consistent with our data, several lines of evidence demonstrate improved wound healing in 
neutrophil-depleted conditions.
35-38
 Indeed, neutrophil infiltration mediates damage through a 
production of proteases
35
, oxidative radicals, elastase
39
, and neutrophil extracellular traps
37
, all of 
which can delay the healing process. A similar effect of fibrin(ogen) might also apply to 
monocyte/macrophage recruitment since fibrinogen has an anti-adhesive effect against monocytes.
40
 
A recent sterile wound model has demonstrated that Ly6C
+
 monocytes are present throughout wound 
healing and differentiate into M1 macrophages during inflammatory phase and M2 macrophages 
during the reparative phase.
41
 In addition, it has been shown that TNF-α secretion is increased during 
monocyte-to-M1-macrophage differentiation.
41,42
 The reduction in TNF-α during the inflammatory 
phase is associated with the increase in wound monocytes but not macrophages suggests an inhibition 
in monocyte-to-M1-macrophage transition in DKO mice, resulting in a significant change in immune 
cell infiltration in the wound.  
Depletion of macrophages in the first five days has previously been shown to delay the later stages of 
wound closure, but not during the inflammatory phase (day 1-3).
43
 This is due to a decrease in M2 
macrophages
43
, supporting our observation that a reduction in wound macrophages, particularly M1 
phenotype, in the early phase does not negatively affect wound closure but may contribute to the 
reduction in scar formation
43
. The alteration in M2 macrophages was not observed in DKO mice 
although the previous dermatitis model has reported an increase number of M2 phenotypes in GPVI-
deficient mice
16
, suggesting other contributing factors for macrophage
 
polarization during skin wound 
healing
6
.  
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The increased risk of wound contamination is a concern in the context of intra-tissue bleeding and 
reduced wound leukocytes. However, it has recently been shown that rapid formation of a fibrin film 
over the surface of the wound is protective against bacterial infection.
44
 This process might also reduce 
the need for leukocyte infiltration to kill microbes. Moreover, a previous study has reported that a two-
fold increase in wound neutrophils is driven by Staphylococcus aureus infection.
45
 Whether the 
beneficial potential of targeting GPVI and CLEC-2 might modulate the risk of wound infection requires 
further investigation. 
In conclusion, we show that deletion of platelet GPVI and CLEC-2 facilitates cutaneous wound repair 
through a local and temporal vascular leakage leading to increased fibrin(ogen) deposition and reduced 
leukocyte infiltration. Thus, impaired vascular integrity due to the loss of GPVI and CLEC-2 is beneficial 
to wound repair. This contrasts with results in coagulation-deficient mice, with differences explained 
by altered formation of fibrin and most likely alteration in immune cell trafficking. A shorter duration of 
healing lowers the risk of complications (e.g. infection) and the cost of wound care.
46
 Based on our 
study, targeting CLEC-2 and GPVI at the wound site together with optimal wound care (e.g. aseptic 
dressing) might represent a new pathway to promote healing and reduce scar formation.  
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Figure legends: 
Figure 1. Podoplanin-expressing cells are present at perivascular area in contact with platelets during 
skin wound repair. (A) Immunofluorescence staining of NG2 (red), podoplanin (green) and CD41 
(white) illustrates platelets and podoplanin-expressing pericytes (NG2
+
) around blood vessel at day 3 
after injury (n=5-7). Hoechst counterstains nuclei (blue). BV = blood vessel. Arrow points to platelets at 
perivascular site. Star indicates extravascular localization of platelets. Scale bar = 20 µm. (B) 
Podoplanin (green) was double-stained with either vimentin (red; top panel) or Ly6C (red; middle 
panel) or F4/80 (red; bottom panel), which are located around blood vessel (surrounded by NG2
+
 
pericytes) at day 3 after injury (n=4-5). Scale bar = 20 µm. 
 
Figure 2. Deletion of platelet ITAM receptors accelerates skin wound repair process. Mice were 
subjected to a full-thickness excisional skin wound and wound closure monitored for 9 days after 
injury. (A) Macroscopic appearance of wound at indicated time points. (B) Changes of wound size over 
9 days post-injury (n=10-13). (C) H&E staining at day 9 post-injury (n=9-13). a = length of hyperplastic 
epidermis, b = inter-subcutaneous distance. Scale bar = 200 µm. (D) Measurement of the length of 
hyperplastic epidermis. (E) Measurement of inter-subcutaneous distance. All graphs are presented as 
mean ± SEM. Kinetics of wound closure (B) are analyzed by two-way ANOVA with Bonferroni’s multiple 
comparison test. *p<0.05, **p<0.01. *WT vs. DKO, 
+
Clec1b
fl/fl
Pf4-cre vs DKO, 
#
Gp6
-/-
 vs. DKO. Other 
parameters are analyzed by one-way ANOVA with Bonferroni’s multiple comparison test. *p<0.05. 
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Figure 3. Enhanced re-epithelialization and angiogenesis occur at the early phase of wound healing in 
the absence of GPVI and CLEC-2. (A) H&E staining at day 3 post-injury (n=6-9). Dotted line indicates 
hyperplastic coverages. Black arrow points to wound edge. Red arrow indicates gap between epithelial 
tongues. S = scab, G = granulation tissue. Scale bar = 500 µm. (B) Measurement of re-epithelialization. 
(C) Measurement of wound contraction. (D) Quantification of granulation tissue area. (E) Detection of 
endothelial cells (CD31
+
 cells; green) in wound area at day 3 post-injury. Hoechst counterstains nuclei 
(blue). Scale bar = 50 µm. (F) Quantification of CD31
+
 area within the wound at day 3 post-injury (n=5-
6). Graphs are presented as mean ± SEM and analyzed by one-way ANOVA with Bonferroni’s multiple 
comparison test. *p<0.05.  
 
Figure 4. Lack of platelet ITAM receptors causes local and temporal bleeding leading to fibrin(ogen) 
deposition during inflammatory phase of wound repair. (A) Macroscopic images of inner side of skin 
wound at day 3 post-injury (n=4-6). Dotted circle indicates wound area. Arrow points to dilated vessel. 
Arrowhead shows bleeding into surrounding skin. (B) Fibrinogen staining (brown) of skin wound at day 
3 post-injury. (C) Quantification of fibrinogen content at day 3 post-injury (n=6). (D) Martius scarlet 
blue (MSB) staining of skin wound at day 3 post-injury. Red = old fibrin, blue = collagen, yellow = red 
blood cells/fresh fibrin. (E) Quantification of fibrin content in the wound at day 3 post-injury (n=6-9). 
(F) MSB staining of wound scar at day 9 post-injury. (G) Quantification of fibrin content in the scar at 
day 9 post-injury (n=9-13). Graphs are presented as mean ± SEM and analyzed by one-way ANOVA with 
Bonferroni’s multiple comparison test. *p<0.05, **p<0.01. Scale bar = 200 µm. 
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Figure 5. Neutrophil influx is decreased during the inflammatory phase of wound healing following 
platelet CLEC-2 and GPVI double-deletion. (A) Detection of neutrophils (Gr-1 staining; brown) in 
wound at day 3 post-injury. (B) Quantification of neutrophils (Gr-1
+
 cells) in wound at day 3 post-injury. 
*p<0.05, **p<0.01. (C) Comparison of Gr1
+
 cells between day 1, day 3, and day 9 post-injury in WT and 
DKO mice. The symbols * and § indicate p<0.05 in WT and DKO mice, compared to the data at day 1 
post-injury, respectively. The bracket shows p<0.05 for the comparison between day 3 and day 9 post-
injury in *WT and 
§
DKO mice, respectively. (D) Detection of neutrophils (Gr-1 staining; brown) in 
wound at day 9 post-injury. (E) Quantification of neutrophils (Gr-1
+
 cells) in wound at day 9 post-injury. 
*p<0.05. (F) Comparison of blood neutrophil counts between baseline, day 3, and day 9 post-injury in 
each mouse strain. The symbols * and + indicate p<0.05 in WT and Clec1b
fl/fl
Pf4-cre mice, compared to 
their control, respectively. Sample numbers in unchallenged control = 10, day 1 = 5, day 3 = 6-9, and 
day 9 post-injury = 9-13, respectively. Graphs are presented as mean ± SEM and analyzed by one-way 
ANOVA with Bonferroni’s multiple comparison test. Scale bar = 20 µm. 
 
Figure 6. A higher number of wound monocytes is observed during the inflammatory phase of repair 
in mice that lack both GPVI and CLEC-2. (A) Detection of monocytes (Ly6C
+
 cells; brown) in wound at 
day 3 post-injury. (B) Quantification of Ly6C
+
 cells in wound at day 3 post-injury (n=5-7). **p<0.01. (C) 
Comparison of Ly6C
+
 cells between day 1, day 3, and day 9 post-injury in WT and DKO mice. The 
symbols * and § indicate p<0.05 in WT and DKO mice, compared to the data at day 1 post-injury, 
respectively. The bracket shows p<0.05 for the comparison between day 3 and day 9 post-injury in 
§
DKO mice. (D) Detection of Ly6C
+
 cells (brown) in wound at day 9 post-injury. (E) Quantification of 
Ly6C
+
 cells in wound at day 9 post-injury (n=6). *p<0.05, **p<0.01. (F) Comparison of blood monocyte 
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counts between baseline, day 3, and day 9 post-injury in each mouse strain. The symbols *, +, #, and § 
indicate p<0.05 in WT, Clec1b
fl/fl
Pf4-cre, Gp6
-/-
, and DKO mice, compared to their control, respectively. 
Sample numbers in unchallenged control = 10, day 1 = 5, day 3 = 6-9, and day 9 post-injury = 10-13, 
respectively. Graphs are presented as mean ± SEM and analyzed by one-way ANOVA with Bonferroni’s 
multiple comparison test. Scale bar = 20 µm. 
 
Figure 7. M1 macrophages and TNF-α level are reduced during the inflammatory phase of wound 
healing in ITAM receptors-deficient mice. (A) Detection of macrophages (F4/80
+
 cells; brown) in 
wound at day 3 post-injury. (B) Quantification of F4/80
+
 cells in wound at day 3 post-injury (n=6-8). 
*p<0.05, **p<0.01. (C) Comparison of F4/80
+
 cells between day 1, day 3, and day 9 post-injury in WT 
and DKO mice. The symbols * and § indicate p<0.05 in WT and DKO mice, compared to the data at day 
1 post-injury, respectively. The bracket shows p<0.05 for the comparison between day 3 and day 9 
post-injury in 
§
DKO mice. Sample numbers at day 1 = 5, day 3 = 6-9, and day 9 post-injury = 10-13, 
respectively. (D) Immunofluorescence double staining of iNOS (red) and F4/80 (green) in the wound of 
WT and DKO mice at day 3 (n=4) and day 9 post-injury (n=4). Hoechst counterstains nuclei (blue). (E) 
Quantification of M1 macrophages (iNOS
+
F4/80
+
 cells; yellow) at day 3 post-injury (n=4). *p<0.05. (F) 
Quantification of M1 macrophages (iNOS
+
F4/80
+
 cells; yellow) at day 9 post-injury (n=4). (G) 
Immunohistochemistry staining of TNF-α (brown) in the wound at day 3 post-injury. (H) Quantification 
of TNF-α level in granulation tissue area at day 3 post-injury (n=6). *p<0.05. Graphs are presented as 
mean ± SEM and analyzed by either Student’s t-test (E, F) or one-way ANOVA with Bonferroni’s 
multiple comparison test (B, C, and H). Scale bar = 20 µm. 
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Figure 8. Anti-podoplanin antibody injection in Gp6
-/- 
mice (Gp6
-/-
 + anti-PDPN) simulates the 
accelerated phenotype of skin wound repair observed in DKO mice. (A) Macroscopic appearance of 
wound at indicated time points. Arrow points to intra-skin bleeding around the wound at day 3 post-
injury. (B) Changes of wound size over 3 days post-injury (n=5). (C) H&E staining at day 3 post-injury 
(n=5). Arrow points the bleeding into surrounding skin. Scale bar = 20 µm. (D) Martius scarlet blue 
staining of skin wound at day 3 post-injury. Red = old fibrin, blue = collagen, yellow = red blood 
cells/fresh fibrin. Scale bar = 200 µm. (E) Quantification of fibrin content (red) in the wound at day 3 
post-injury (n=5). (F) Staining of neutrophils (Gr-1; brown) in wound area at day 3 post-injury. (G) 
Quantification of neutrophils (Gr-1
+
 cells) in wound area at day 3 post-injury (n=5). (H) Detection of 
macrophages (F4/80 staining; brown) in wound area at day 3 post-injury. (I) Quantification of 
macrophages (F4/80
+
 cells) in wound area at day 3 post-injury (n=5). All graphs are presented as mean 
± SEM. Kinetics of wound closure (B) are analyzed by two-way ANOVA with Bonferroni’s multiple 
comparison test. Other parameters are analyzed by Student’s t-test. *p<0.05. 
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Supplemental materials 
 
Supplemental methods: 
 
Animal 
In this study, C57BL/6 mice were bred to produce wild type (WT) and platelet-specific CLEC-2-deficient 
(Clec1bfl/flPf4-Cre)1 mice as littermates separately from GPVI knockout (Gp6
-/-)2 and CLEC-2/GPVI 
double-deficient (Clec1bfl/flPf4-Cre/Gp6-/-; DKO) mice. Additionally, Clec1bfl/flPf4-Cre mice were used for 
breeding in the DKO producing colony. Cross comparisons were made between related, age- and sex-
matched animals to control natural variation between mouse strains, including between WT and DKO 
mice.  
 
Morphometric analysis 
Wounds were excised, fixed in 4% paraformaldehyde and processed using a standard paraffin 
embedding protocol. Paraffin-embedded skin samples (5 µm) were used for hematoxylin and eosin 
(H&E) staining. Tissues were imaged using a ZEISS AxioScan.Z1 slide scanner. As shown in the scheme 
below, the proliferation of keratinocytes forms the hyperplastic epidermis (He) at the wound edge 
within a few days after injury. The granulation tissue, containing newly formed blood vessels, 
infiltrating cells, and molecules, is also formed to facilitate wound healing. Keratinocytes migrate 
underneath the scab and above the granulation tissue, which generate epithelial tongues toward the 
centre of the wound to resurface skin epidermis (the tips of epithelial tongue are indicated by red 
arrow).3-5 Morphometric analysis of skin histology was performed manually using a freehand line tool 
in Fiji (a distribution of ImageJ software)6, and the terms were defined in the following ways; 
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 Re-epithelialization is the re-generation of skin epidermis.7,8 The area of thickening 
keratinocytes immediately next to the normal skin in histology images is considered as the 
wound edge for measuring re-epithelialization.8-13 Percentage of re-epithelialization at day 3 
post-injury was calculated using the formula8,9; 
 
% Re-epithelialization = [(E1+E2)/W0] x 100 
 
where E1 and E2  = distance of epithelial tongue from each side of wound edge 
            W0 = original wound diameter at day 0 
 
 Wound contraction, which is mediated by the specialized muscle called “panniculus carnosus 
(PC)” in deeper layer of murine skin, also affects wound closure.14 To exclude the influence of 
this effect, closure by contraction at day 3 post-injury was calculated using the formula9;  
 
% Wound contraction = [(W0-WT)/W0] x 100 
 
where WT = distance between the wound edges at indicated time point 
 
 
Day 3 post-injury 
 
 
Scab 
Sc 
Wound 
edge 
Granulation 
tissue 
Wound 
edge 
He He 
Dermis 
WT 
E1 E2 
PC PC X 
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 The area of granulation tissue, which contributes to new tissue re-formation, was also 
measured at day 3 post-injury.4,5 
 Following the complete wound closure, thickened layer of keratinocytes is remained, known as 
scar. Thus, the length of hyperplastic epidermis (“a” in Figure 2C), which indicates the size of 
scar at upper layer, was examined at day 9 post-injury.5,15 
 Measurement of distance between intact subcutaneous (Sc) edges at both side of the wound 
(“X” in above scheme and “b” in Figure 2C), which represents the size of scar in the deeper 
layer, was also performed at day 9 post-injury.5 
 
Measurement of fibrin and collagen contents 
Martius scarlet blue staining (Atom Scientific, UK) was used to detect fibrin and collagen. High power 
field (HPF) images were taken from the whole wound area. To calculate the mean intensity, the fibrin 
(red color) and collagen signals (blue color) were isolated using the Fiji Colour Deconvolution plugin 
(Masson Trichrome)16 and the threshold set using the Otsu method17. A total intensity was normalized 
by total measured area, and expressed as fold relative to WT. 
 
Immunohistochemistry and immunofluorescence 
Immunohistochemistry staining for Gr-1, Ly6C, F4/80, fibrinogen, tissue factor (TF), tumor necrosis 
factor (TNF)-α, platelet factor 4 (PF4), CXCL-1 and podoplanin were performed on paraffin-embedded 
skin section (5 µm) according to a standard protocol18; horseradish peroxidase (HRP)-conjugated 
secondary antibodies and ImpactDAB substrate (SK-4105, Vector Lab) were used for signal detection. 
HPF images were taken from the whole wound area. Brown color was separated using IHC toolbox in 
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Fiji then thresholded (Otsu). The binary images were processed by filling holes and a watershed 
transform to separate touching cells. Per cell measurements were calculated for all connected areas 
larger than 45 square microns.  Gr-1+, Ly6C+ and F4/80+ cells were counted and presented per HPF19, 
while intensity of TF20, TNF-α, PF4, and CXCL-121 were quantified and normalized by total measured 
area, then expressed as fold relative to wild-type (WT). 
 
Immunofluorescence staining for neuron-glial antigen 2 (NG2), CD41, podoplanin, vimentin, Ly6C, 
Ly6G, iNOS, Fizz-1, F4/80, and CD31 were processed in optimal cutting temperature compound (O.C.T)-
embedded frozen skin sections (10 µm). Fluorophore-conjugated secondary antibodies were used to 
detect signals. Hoechst (H3570, Life Technologies) was used to stain nuclei. HPF images were taken 
from the whole wound area. CD31+ area22 was calculated using Otsu thresholding (Fiji) and normalized 
by total measured area, and presented as fold relative to WT. The iNOS+F4/80+ cells and Fizz-1+F4/80+ 
cells were counted using Fiji according to the previous protocol23 with adaptation. In brief, HPF image 
of either iNOS+F4/80+ or Fizz-1+F4/80+ double staining was split into a single blue (nuclei), green 
(F4/80) and red (iNOS or Fizz-1) channel, respectively. The threshold of green fluorescence was set 
using Otsu model. Then, the binary images were processed by a watershed to separate attached 
particles. The red fluorescence was also thresholded. To create a merged image of previously 
processed red and green channels, the “image calculator” mode from process menu was used, 
followed by choosing the operator “AND”. Finally, all connected areas larger than 45 square microns 
were counted as per cell measurements. The antibodies used are described in Table S1. 
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In vitro neutrophil migration assay 
Neutrophils were isolated from the bone marrow of WT or DKO mice as previously described24 and 
purity was checked using anti-Ly6G antibody. Isolated neutrophils (50,000 cells diluted in Hank’s 
Balanced Salt Solution + 0.5 % bovine serum albumin) were loaded into the upper well of a chemotaxis 
chip (Ibidis). The chemotaxis chips were coated with collagen (10μg/ml), fibrinogen (100 μg/ml) or 
crosslinked fibrin (prepared by mixing fibrinogen (1 mg/ml), thrombin (1 U/ml), Ca2+ (10 mM), and 
FXIIIa (7 μg/ml) in PBS for 1 hour at 37 °C). Chemotaxis toward fMLP (5 µM, Sigma) was assessed for 3 
hours. After fixation with formalin, the cells in the loaded and migrated wells were imaged, and the 
number of cells in five representative areas per sample was quantified using Fiji. Finally, percentage of 
migrated cells was calculated using the formula;  
Percent neutrophil migration = [N1/(N1+N2)] x 100 
             Where N1 = numbers of migrated cells, N2 = numbers of remaining cells in loaded chamber 
 
Hematological analysis 
Whole blood was collected from the inferior vena cava using ethylenediaminetetraacetic acid (EDTA)-
filled syringe. Blood counts were analyzed on an ABX Pentra 60 (Horbia Ltd, UK).  
 
Statistical analysis 
All data are presented as mean ± standard error of mean (SEM). Two-way ANOVA with Bonferroni’s 
multiple comparison test was used to compare kinetics of wound closure. Mean differences in other 
parameters were analyzed by either Student’s t-test (two groups comparison) or one-way ANOVA with 
Bonferroni post-hoc test (more than two groups) using GraphPad Prism software. p<0.05 was 
considered as statistically significant. 
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Table S1. List of antibodies used in immunostaining 
Reagents Working dilution Company Cat No. 
Primary antibodies 
Rat anti-mouse Gr-1 monoclonal antibody 1:200 eBiosciences 14-5931-82 
Rat anti-mouse F4/80 monoclonal antibody 1:200 (IHC) 
1:100 (IF) 
Bio-Rad MCA497GA 
Rabbit anti-mouse CXCL-1 monoclonal antibody 1:200 R&D systems MAB4532 
Syrian hamster anti-mouse podoplanin 
monoclonal antibody 
1:500 (IHC) 
1:200 (IF) 
eBiosciences 14-5381-85 
Rat anti-mouse CD41 monoclonal antibody 1:100 BD Pharmagen 553847 
Rabbit anti-CD31 polyclonal antibody 1:100 Abcam ab28364 
Rabbit anti-NG2 chondroitin sulfate proteoglycan 
polyclonal antibody 
1:200 Merk Millipore AB5320 
Rabbit anti-tissue factor monoclonal antibody 1:400 Abcam ab151748 
Rabbit anti-TNF alpha polyclonal antibody 1:200 Abcam ab9739 
Rat anti-mouse Ly6C monoclonal antibody 1:200 Biolegend 128002 
Rat anti-mouse CXCL4/PF4 monoclonal antibody 1:200 R&D systems MAB595-100 
Goat anti-mouse fibrinogen polyclonal antibody 1:200 Accurate Chemical & 
Scientific Corp. 
YNGMFBG7S 
Rabbit anti-vimentin monoclonal antibody 1:200 R&D systems MAB2105 
Rabbit anti-iNOS polyclonal antibody  1:50 Abcam ab15323 
Rabbit anti-RELM alpha (Fizz-1) polyclonal 
antibody  
1:50 Abcam ab39626  
Rat anti-mouse Ly6G-APC/Cy7-conjugated 
monoclonal antibody (clone 1A8) 
1:100 BD Pharmagen 560600 
IgG control 
Rat IgG2b control 1:400 Bio-Rad MCA1125 
Rat IgG1,Ƙ control 1:200 Biolegend 400402 
Golden Syrian hamster IgG control 1:500 (IHC) 
1:200 (IF) 
eBiosciences 14-4914-85 
Rabbit IgG control 1: 10,000 Life technologies 10500C 
Secondary antibodies 
Goat anti-rat IgG-HRP 1:200 (Gr-1) 
1:500 (F4/80) 
Santa Cruz sc-2032 
Goat anti-hamster IgG-HRP 1:500 Santa Cruz sc-2905 
Donkey anti-rabbit IgG-HRP 1:200 GE Healthcare NA934V 
Donkey anti-goat IgG-HRP 1:500 Santa Cruz Sc-2020 
Goat anti-rat IgG-Alexa 568 1:200 Life technologies A11077 
Goat anti-rat IgG-Alexa 488 1:200 (vimentin) 
1:100 (F4/80) 
Life technologies A11006 
Goat anti-hamster IgG-Alexa 488 1:200 Life technologies A21110 
Goat anti-rabbit IgG-Alexa 647 1:200 
1:100 (iNOS and Fizz-1) 
Life technologies A21245 
Hoechst 1:10,000 Life technologies H3570 
IHC = Immunohistochemistry, IF = Immunofluorescence 
 
 
7 
 
References 
1. Finney BA, Schweighoffer E, Navarro-Nunez L, et al. CLEC-2 and Syk in the megakaryocytic/platelet 
lineage are essential for development. Blood. 2012;119(7):1747-1756. 
2. Kato K, Kanaji T, Russell S, et al. The contribution of glycoprotein VI to stable platelet adhesion and 
thrombus formation illustrated by targeted gene deletion. Blood. 2003;102(5):1701-1707. 
3. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci. 2009;122(Pt 18):3209-3213. 
4. Lucas T, Waisman A, Ranjan R, et al. Differential roles of macrophages in diverse phases of skin 
repair. J Immunol. 2010;184(7):3964-3977. 
5. Yang HS, Shin J, Bhang SH, et al. Enhanced skin wound healing by a sustained release of growth 
factors contained in platelet-rich plasma. Exp Mol Med. 2011;43(11):622-629. 
6. Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image 
analysis. Nat Methods. 2012;9(7):676-682. 
7. Ben Amar M, Wu M. Re-epithelialization: advancing epithelium frontier during wound healing. J R 
Soc Interface. 2014;11(93):20131038. 
8. Stavrou EX, Fang C, Bane KL, et al. Factor XII and uPAR upregulate neutrophil functions to 
influence wound healing. J Clin Invest. 2018;128(3):944-959. 
9. Chen L, Mirza R, Kwon Y, DiPietro LA, Koh TJ. The murine excisional wound model: Contraction 
revisited. Wound Repair Regen. 2015;23(6):874-877. 
10. Oda Y, Hu L, Nguyen T, Fong C, Tu CL, Bikle DD. Combined Deletion of the Vitamin D Receptor and 
Calcium-Sensing Receptor Delays Wound Re-epithelialization. Endocrinology. 2017;158(6):1929-
1938. 
11. Sheets AR, Demidova-Rice TN, Shi L, Ronfard V, Grover KV, Herman IM. Identification and 
Characterization of Novel Matrix-Derived Bioactive Peptides: A Role for Collagenase from Santyl(R) 
Ointment in Post-Debridement Wound Healing? PLoS One. 2016;11(7):e0159598. 
12. Carretero M, Escamez MJ, Garcia M, et al. In vitro and in vivo wound healing-promoting activities 
of human cathelicidin LL-37. J Invest Dermatol. 2008;128(1):223-236. 
13. Schmidt BA, Horsley V. Intradermal adipocytes mediate fibroblast recruitment during skin wound 
healing. Development. 2013;140(7):1517-1527. 
8 
 
14. Davidson JM, Yu F, Opalenik SR. Splinting Strategies to Overcome Confounding Wound Contraction 
in Experimental Animal Models. Adv Wound Care (New Rochelle). 2013;2(4):142-148. 
15. Rono B, Engelholm LH, Lund LR, Hald A. Gender affects skin wound healing in plasminogen 
deficient mice. PLoS One. 2013;8(3):e59942. 
16. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal 
Quant Cytol Histol. 2001;23(4):291-299. 
17. Luo TL, Eisenberg MC, Hayashi MAL, et al. A Sensitive Thresholding Method for Confocal Laser 
Scanning Microscope Image Stacks of Microbial Biofilms. Sci Rep. 2018;8(1):13013. 
18. Ramos-Vara JA. Principles and Methods of Immunohistochemistry. Methods Mol Biol. 
2017;1641:115-128. 
19. Qiang L, Sample A, Liu H, Wu X, He YY. Epidermal SIRT1 regulates inflammation, cell migration, and 
wound healing. Sci Rep. 2017;7(1):14110. 
20. Zhou J, May L, Liao P, Gross PL, Weitz JI. Inferior vena cava ligation rapidly induces tissue factor 
expression and venous thrombosis in rats. Arterioscler Thromb Vasc Biol. 2009;29(6):863-869. 
21. Smith E, Prasad KM, Butcher M, et al. Blockade of interleukin-17A results in reduced 
atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2010;121(15):1746-1755. 
22. Uchiyama A, Yamada K, Ogino S, et al. MFG-E8 regulates angiogenesis in cutaneous wound 
healing. Am J Pathol. 2014;184(7):1981-1990. 
23. Arqués O, Chicote I, Tenbaum S, Puig I, Palmer HG. Standardized Relative Quantification of 
Immunofluorescence Tissue Staining. Protocol Exchange 2012. 
24. Swamydas M, Lionakis MS. Isolation, purification and labeling of mouse bone marrow neutrophils 
for functional studies and adoptive transfer experiments. J Vis Exp. 2013(77):e50586. 
 
 
 
 
 
 
 
 
 
 
9 
 
Supplemental Figures: 
 
Figure S1 
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Figure S1. Platelet CLEC-2 deficient mice and DKO mice have lower baseline platelet counts than WT 
but no alteration in density of blood and lymphatic vessels in skin tissues. (A) Martius scarlet blue 
(MSB) staining shows collagen (blue) in dermis and hypodermis of unchallenged WT mouse skin (n=5). 
Red = old fibrin, blue = collagen, yellow = red blood cells/fresh fibrin. Scale bar = 100 µm. (B) 
Immunohistochemistry of podoplanin (brown) in unchallenged WT mouse skin (n=5). L = lymphatic 
vessel, KC = keratinocyte. PDPN = podoplanin. BV = blood vessel. Scale bar = 100 µm. (C)  Podoplanin 
immunohistochemistry staining (brown) of skin wound at day 3 post-injury shows upregulation of 
podoplanin on migrating keratinocytes and on stromal and infiltrating cells within the granulation 
tissue in all groups (n=6-9). Scale bar = 500 µm. (D) Comparison of platelet counts between baseline, 
day 3, and day 9 post-injury in each mouse strain. Sample numbers (n) at baseline = 10, day 3 post-
injury = 6-9, and day 9 post-injury = 10-13, respectively. **p<0.01. (E) Immunofluorescence staining of 
CD31 (green) in unchallenged skin of WT and genetically modified mice (n=5). Hoechst counterstains 
nuclei (blue). Scale bar = 50 µm. (F) Immunohistochemistry staining shows podoplanin (brown) on 
lymphatic vessels in unchallenged skin of WT and genetically modified mice (n=5). PDPN = podoplanin. 
Scale bar = 50 µm. 
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Figure S2 
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Figure S2. Vascular leakage is observed in DKO mice and less marked in Gp6-/- mice during the 
inflammatory phase of wound healing. (A) H&E staining of wounds at day 3 post-injury (n=6-9). Arrow 
indicates bleeding into surrounding skin. Scale bar = 50 µm. (B) H&E staining of wound scar at day 9 
post-injury (n=10-13). Arrow indicates red blood cells within the vessel. Scale bar = 20 µm. (C) 
Immunohistochemistry shows podoplanin on lymphatic endothelium (upper panel) and cells around 
blood vessel (lower panel). L = lymphatic vessel. BV = blood vessel. Arrow points to red blood cells in 
both types of vasculature. Scale bar = 20 µm.  
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Figure S3 
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Figure S3. Normal TF, (myo)fibroblasts, and collagen content in DKO during the course of skin wound 
healing. (A) Immunohistochemistry staining of tissue factor (brown) at day 3 post-injury. TF = tissue 
factor. Scale bar = 50 µm. (B) Quantification of tissue factor at day 3 post-injury (n=5-6). (C) Martius 
scarlet blue (MSB) staining of skin wound at day 1 post-injury. Red = old fibrin, blue = collagen, yellow = 
red blood cells/fresh fibrin. Scale bar = 200 µm. (D) Quantification of fibrin content in the wound at day 
1 post-injury (n=5). (E) Immunofluorescence staining of (myo)fibroblasts (vimentin+ cells; red) in the 
wound of WT and DKO mice at day 3 (n=4) and day 9 post-injury (n=3). Hoechst counterstains nuclei 
(blue). Scale bar = 20 µm. (F) Quantification of (myo)fibroblasts (vimentin+ cells) at day 3 post-injury 
(n=4). (G) Quantification of (myo)fibroblasts (vimentin+ cells) at day 9 post-injury (n=3). (H) 
Quantification of collagen content (blue color) in MSB staining within the wound at day 3 post-injury 
(n=7-9). (I) Quantification of collagen content within the scar at day 9 post-injury (n=9-13). Graphs are 
presented as mean ± SEM and analyzed by either one-way ANOVA with Bonferroni’s multiple 
comparison test (B) or Student’s t-test (D, F, G, H, and I). 
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Figure S4 
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Figure S4. Wound neutrophils and monocytes are unaltered but macrophage influx is decreased in 
DKO mice at day 1 post-injury. (A) Staining of neutrophils (Gr-1; brown) in wound area at day 1 post-
injury. (B) Quantification of neutrophils (Gr-1+ cells) in wound area at day 1 post-injury (n=5). (C) 
Staining of monocytes (Ly6C+; brown) in wound area at day 1 post-injury. (D) Quantification of 
monocytes (Ly6C+ cells) in wound area at day 1 post-injury (n=5). (E) Detection of macrophages (F4/80 
staining; brown) in wound area at day 1 post-injury. (F) Quantification of macrophages (F4/80+ cells) in 
wound area at day 1 post-injury (n=5). (G) Comparison of blood monocytes between all groups at 
baseline (left), day 3 (middle), and day 9 post-injury (right). Graphs are presented as mean ± SEM and 
analyzed by either Student’s t-test (B, D, and F) or one-way ANOVA with Bonferroni’s multiple 
comparison test (G). *p<0.05, **p<0.01. Scale bar = 200 µm (upper panel), and 20 µm (lower panel). 
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Figure S5 
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Figure S5. Normal M2 macrophage recruitment in DKO mice during the course of wound healing. (A) 
Immunofluorescence double staining of Fizz-1 (red) and F4/80 (green) in the wound of WT and DKO 
mice at day 3 (n=4) and day 9 post-injury (n=4). Hoechst counterstains nuclei (blue). Scale bar = 20 µm. 
(B) Quantification of M2 macrophages (Fizz-1+F4/80+ cells; yellow) at day 3 post-injury (n=4). (C) 
Quantification of M2 macrophages (Fizz-1+F4/80+ cells; yellow) at day 9 post-injury (n=4). (D) Detection 
of F4/80+ cells (brown) in wound at day 9 post-injury. Scale bar = 20 µm. (E) Quantification of F4/80+ 
cells in wound at day 9 post-injury (n=10-13). Graphs are presented as mean ± SEM and analyzed by 
either Student’s t-test (B and C) or one-way ANOVA with Bonferroni’s multiple comparison test (E). *p 
<0.05. 
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Figure S6 
 
 
 
Figure S6. Normal expression of CXCL-1 and PF-4 at day 3 post-injury in DKO mice. (A) Detection of 
CXCL-1 (brown) in wound area at day 3 post-injury. (B) Quantification of keratinocyte-expressed CXCL-1 
in wound area at day 3 post-injury (n=6). (C) Detection of PF4 (brown) in wound area at day 3 post-
injury. (D) Quantification of PF4 within the granulation tissue in wound area at day 3 post-injury (n=6). 
Data are presented as mean ± SEM and analyzed by one-way ANOVA with Bonferroni’s multiple 
comparison test. Scale bar = 20 µm. 
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Figure S7 
 
 
 
 
 
Figure S7. Fibrinogen and crosslinked fibrin matrix attenuate neutrophil chemotaxis in vitro. Graphs 
represent migration of neutrophils through collagen, fibrinogen, and fibrin matrix (n=3). Data are 
presented as mean ± SEM and analyzed by one-way ANOVA. *p<0.05, **p<0.01.  
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Figure S8 
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Figure S8. Increased wound monocytes, enhanced angiogenesis, rapid re-epithelialization and 
greater granulation tissue formation in Gp6-/- mice treated with anti-podoplanin antibody. (A) 
Detection of Ly6C+ cells (brown) in wound at day 3 post-injury. Scale bar = 20 µm. (B) Quantification of 
Ly6C+ cells in wound at day 3 post-injury (n=5). (C) Immunohistochemistry staining of TNF-α (brown) in 
the wound at day 3 post-injury. Scale bar = 20 µm. (D) Quantification of TNF-α level in granulation 
tissue area at day 3 post-injury (n=5). (E) H&E staining at day 3 post-injury. Dotted line indicates 
hyperplastic coverages. Arrow indicates gap between epithelial tongues. Scale bar = 500 µm. (F) 
Measurement of re-epithelialization (n=5). (G) Measurement of wound contraction (n=5). (H) 
Quantification of granulation tissue area (n=5). (I) Immunofluorescence staining of endothelial cells 
(CD31+ cells; green) in wound area at day 3 post-injury. Hoechst counterstains nuclei (blue). Scale bar = 
50 µm. (J) Quantification of CD31+ area within the wound at day 3 post-injury (n=5). All graphs are 
presented as mean ± SEM and analyzed by Student’s t-test. *p<0.05. NS = non-significant. 
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Figure S9 
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Figure S9. Anti-podoplanin antibody (PDPN-Ab) is detected together with extravascular platelets at 
perivascular area in Gp6-/- mice treated with this antibody. Immunofluorescence staining of NG2 
(red), PDPN-Ab (green) and CD41 (white) illustrates extravasation of platelets and the presence of 
PDPN-Ab on pericytes (NG2+) and other cells around blood vessel at day 3 after injury (n=4-5). Alexa 
488-conjugated goat anti-hamster IgG secondary antibody was used in immunofluorescence to detect 
the injected PDPN-Ab (clone 8.1.1.). Hoechst counterstains nuclei (blue). BV = blood vessel. Scale bar = 
20 µm. 
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Figure S10 
 
 
 
 
 
Figure S10. Schematic illustration for multifactorial contribution of accelerated skin wound healing in 
the absence of platelet ITAM receptors. A lack of GPVI and CLEC-2 results in transient vascular 
leakage, which contributes to higher fibrin(ogen) content at wound site. In addition, plasma-derived 
macromolecules (e.g. clotting factors, growth factors, and cytokines) may also leak into the wound. 
Moreover, ITAM-receptor deficiency decreases wound leukocytes during inflammatory phase, likely 
because of a physical blockade by fibrin(ogen) and a decrease in neutrophil capacity to migrate 
through fibrinogen, which subsequently attenuates inflammation and tissue damage. These two 
mechanisms associate with an accelerated skin wound healing, at least by facilitating re-
epithelialization and angiogenesis. EC = endothelial cells, KC = keratinocytes. 
 
